FLT4 and colorectal carcinoma: In addition, we determined the usefulness as candidate biomarkers in plasma of the significant effectors able to discriminate CRC and premalignant individuals from controls (BDNF and VEGFR3) calculating its individual sensitivity and specificity by means of ROC curves.